RVNC
PNC Financial Services Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-210
| Closed | -$1.03K | – | 4939 |
|
|
2024
Q1 | $1.03K | Sell |
210
-33
| -14% | -$162 | ﹤0.01% | 4361 |
|
|
2023
Q4 | $2.14K | Sell |
243
-65
| -21% | -$571 | ﹤0.01% | 4178 |
|
|
2023
Q3 | $3.53K | Sell |
308
-121
| -28% | -$1.39K | ﹤0.01% | 4086 |
|
|
2023
Q2 | $10.9K | Sell |
429
-221
| -34% | -$5.59K | ﹤0.01% | 3842 |
|
|
2023
Q1 | $20.9K | Hold |
650
| – | – | ﹤0.01% | 3472 |
|
|
2022
Q4 | $12K | Buy |
650
+178
| +38% | +$3.29K | ﹤0.01% | 3706 |
|
|
2022
Q3 | $13K | Hold |
472
| – | – | ﹤0.01% | 3651 |
|
|
2022
Q2 | $6K | Hold |
472
| – | – | ﹤0.01% | 3965 |
|
|
2022
Q1 | $10K | Sell |
472
-3,596
| -88% | -$76.2K | ﹤0.01% | 3837 |
|
|
2021
Q4 | $68K | Buy |
4,068
+3,583
| +739% | +$59.9K | ﹤0.01% | 2937 |
|
|
2021
Q3 | $14K | Hold |
485
| – | – | ﹤0.01% | 3651 |
|
|
2021
Q2 | $14K | Hold |
485
| – | – | ﹤0.01% | 3608 |
|
|
2021
Q1 | $14K | Buy |
485
+320
| +194% | +$9.24K | ﹤0.01% | 3553 |
|
|
2020
Q4 | $5K | Hold |
165
| – | – | ﹤0.01% | 3727 |
|
|
2020
Q3 | $5K | Hold |
165
| – | – | ﹤0.01% | 3686 |
|
|
2020
Q2 | $5K | Buy |
165
+33
| +25% | +$1K | ﹤0.01% | 3654 |
|
|
2020
Q1 | $1K | Hold |
132
| – | – | ﹤0.01% | 3839 |
|
|
2019
Q4 | $1K | Buy |
132
+84
| +175% | +$636 | ﹤0.01% | 3912 |
|
|
2019
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 4130 |
|
|
2019
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 4155 |
|
|
2019
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 4151 |
|
|
2018
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 4204 |
|
|
2018
Q3 | $2K | Hold |
48
| – | – | ﹤0.01% | 3978 |
|
|
2018
Q2 | $2K | Hold |
48
| – | – | ﹤0.01% | 4003 |
|
|
2018
Q1 | $2K | Hold |
48
| – | – | ﹤0.01% | 4066 |
|
|
2017
Q4 | $2K | Buy |
+48
| New | +$2K | ﹤0.01% | 4028 |
|